Skip to main content
. Author manuscript; available in PMC: 2022 May 25.
Published in final edited form as: Am J Med. 2021 Jun 30;134(11):1371–1379.e2. doi: 10.1016/j.amjmed.2021.05.022

Table 2.

Outcomes and Resource Utilization of Heart Failure Hospitalizations with and Without Type 2 MI

Outcomes Type II MI
OR (95% CI)
P Value
No (n = 1,044,128) Yes (n = 28,823) Unadjusted Adjusted*

In-Hospital Mortality 16,614(1.6) 768(2.7) 1.69(1.50–1.91) 1.53(1.37–1.72) <.001
LOS, Days (mean [SE]) 5(0.02) 6(0.07) 0.63(0.5–0.75) 0.53(0.42–0.64) <.001
Hospital Costs, (mean [SE]) US$ 10,586(96.9) 12,545(237.1) 1959(1538–2379) 1785(1388–2182) <.001
Discharge to Nursing Facility 201,669(19.3) 6530(22.6) 1.22(1.14–1.31) 1.22(1.15–1.29) <.001
30-day All-Cause Readmission 179,678(21.2) 5187(22.5) 1.08(1.03–1.14) 1.06(1.01–1.12) .037

CI = confidence interval; LOS = length of stay; MI = myocardial infarction; OR = odds ratio; SE = standard error.

*

Multivariate model adjusted for age, sex, admission status, and all baseline/hospital characteristics listed in Table 1.

β coefficient and corresponding 95% CI.

Among patients discharged alive.Numbers are frequency (%) unless specified otherwise.